Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by Capital Investment Advisors LLC

Capital Investment Advisors LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 179.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 2,508 shares of the medical equipment provider’s stock after acquiring an additional 1,609 shares during the period. Capital Investment Advisors LLC’s holdings in Intuitive Surgical were worth $1,242,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of ISRG. Atala Financial Inc acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth $25,000. Parvin Asset Management LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth $26,000. Global Financial Private Client LLC increased its holdings in shares of Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 38 shares during the last quarter. BankPlus Trust Department acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth $28,000. Finally, Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth $28,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $526.15 on Tuesday. The firm has a 50-day moving average of $522.38 and a two-hundred day moving average of $539.01. The stock has a market cap of $188.58 billion, a P/E ratio of 82.08, a PEG ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a 1-year low of $413.52 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the prior year, the company posted $1.50 EPS. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Gary Loeb sold 1,700 shares of the stock in a transaction dated Friday, April 25th. The shares were sold at an average price of $513.18, for a total transaction of $872,406.00. Following the transaction, the executive vice president now owns 2,245 shares of the company’s stock, valued at approximately $1,152,089.10. This trade represents a 43.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 215 shares of the stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $549.06, for a total transaction of $118,047.90. Following the transaction, the senior vice president now directly owns 1,768 shares in the company, valued at $970,738.08. The trade was a 10.84% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 16,543 shares of company stock valued at $8,375,072 in the last ninety days. Insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research analyst reports. Evercore ISI dropped their price objective on Intuitive Surgical from $510.00 to $470.00 and set an “in-line” rating for the company in a report on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a report on Monday, April 14th. Royal Bank of Canada dropped their price objective on Intuitive Surgical from $630.00 to $605.00 and set an “outperform” rating for the company in a report on Wednesday, April 23rd. Truist Financial lowered their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a report on Wednesday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a “hold” rating to a “sell” rating and lowered their price target for the company from $515.00 to $440.00 in a report on Monday. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $588.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.